We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (Gemtrans)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01343121
Recruitment Status : Unknown
Verified January 2016 by Suzanne Rowland, Christie Hospital NHS Foundation Trust.
Recruitment status was:  Active, not recruiting
First Posted : April 27, 2011
Last Update Posted : January 27, 2016
University of Oxford
Information provided by (Responsible Party):
Suzanne Rowland, Christie Hospital NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : September 2015
  Estimated Study Completion Date : January 2018